Logo image of XOG

Extraction Oil & Gas Inc (XOG) Stock Fundamental Analysis

NASDAQ:XOG - Nasdaq -

68.54  +1.91 (+2.87%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to XOG. XOG was compared to 213 industry peers in the Oil, Gas & Consumable Fuels industry. XOG may be in some trouble as it scores bad on both profitability and health. XOG is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year XOG was profitable.
XOG Yearly Net Income VS EBIT VS OCF VS FCFXOG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 0 500M -500M -1B

1.2 Ratios

Industry RankSector Rank
ROA -0.04%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XOG Yearly ROA, ROE, ROICXOG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 0 100 -100 -200 -300

1.3 Margins

Industry RankSector Rank
OM -3.63%
PM (TTM) -0.07%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XOG Yearly Profit, Operating, Gross MarginsXOG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 0 -100 -200

More info and screens

2

2. Health

2.1 Basic Checks

XOG has less shares outstanding than it did 1 year ago.
XOG has a better debt/assets ratio than last year.
XOG Yearly Shares OutstandingXOG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 50M 100M 150M
XOG Yearly Total Debt VS Total AssetsXOG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 2.28 indicates that XOG is not a great score, but indicates only limited risk for bankruptcy at the moment.
A Debt/Equity ratio of 0.14 indicates that XOG is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z 2.28
ROIC/WACCN/A
WACCN/A
XOG Yearly LT Debt VS Equity VS FCFXOG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 0 1B -1B

2.3 Liquidity

XOG has a Current Ratio of 0.40. This is a bad value and indicates that XOG is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.35 indicates that XOG may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.4
Quick Ratio 0.35
XOG Yearly Current Assets VS Current LiabilitesXOG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 200M 400M 600M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 366.67% over the past year.
XOG shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.39%.
Measured over the past years, XOG shows a very strong growth in Revenue. The Revenue has been growing by 23.05% on average per year.
EPS 1Y (TTM)366.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%147.69%
Revenue 1Y (TTM)22.39%
Revenue growth 3Y-2.63%
Revenue growth 5Y23.05%
Sales Q2Q%254.24%

3.2 Future

Based on estimates for the next years, XOG will show a very strong growth in Earnings Per Share. The EPS will grow by 25.52% on average per year.
XOG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.51% yearly.
EPS Next Y506.28%
EPS Next 2Y109.66%
EPS Next 3Y60.03%
EPS Next 5Y25.52%
Revenue Next Year65.89%
Revenue Next 2Y24.93%
Revenue Next 3Y9.39%
Revenue Next 5Y0.51%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
XOG Yearly Revenue VS EstimatesXOG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
XOG Yearly EPS VS EstimatesXOG Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

XOG is valuated correctly with a Price/Earnings ratio of 13.82.
Compared to an average S&P500 Price/Earnings ratio of 26.31, XOG is valued a bit cheaper.
A Price/Forward Earnings ratio of 7.17 indicates a rather cheap valuation of XOG.
XOG's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.13.
Industry RankSector Rank
PE 13.82
Fwd PE 7.17
XOG Price Earnings VS Forward Price EarningsXOG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.33
XOG Per share dataXOG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

XOG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
XOG's earnings are expected to grow with 60.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.03
PEG (5Y)N/A
EPS Next 2Y109.66%
EPS Next 3Y60.03%

More info and screens

0

5. Dividend

5.1 Amount

XOG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Extraction Oil & Gas Inc

NASDAQ:XOG (11/1/2021, 8:41:27 PM)

68.54

+1.91 (+2.87%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-08 2021-11-08
Earnings (Next)03-17 2022-03-17/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners200.24%
Ins Owner Change0%
Market Cap1.81B
Analysts76.67
Price Target72.42 (5.66%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 13.82
Fwd PE 7.17
P/S 2.09
P/FCF N/A
P/OCF N/A
P/B 2.66
P/tB N/A
EV/EBITDA 7.33
EPS(TTM)4.96
EY7.24%
EPS(NY)9.56
Fwd EY13.95%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS32.73
BVpS25.75
TBVpSN/A
PEG (NY)0.03
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.04%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -3.63%
PM (TTM) -0.07%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.4
Quick Ratio 0.35
Altman-Z 2.28
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)366.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%147.69%
EPS Next Y506.28%
EPS Next 2Y109.66%
EPS Next 3Y60.03%
EPS Next 5Y25.52%
Revenue 1Y (TTM)22.39%
Revenue growth 3Y-2.63%
Revenue growth 5Y23.05%
Sales Q2Q%254.24%
Revenue Next Year65.89%
Revenue Next 2Y24.93%
Revenue Next 3Y9.39%
Revenue Next 5Y0.51%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A